Case Study Highlights That Autoimmune Diseases Can Trigger a Devastating Stroke and That COVID-19 Can Aggravate the Situation
Nikhil Prasad Fact checked by:Thailand Medical News Team Jun 07, 2026 1 hour, 17 minutes ago
Medical News: A newly published medical case report is drawing attention to a little-known autoimmune disease that can trigger devastating strokes and leave patients with irreversible neurological damage. The report also highlights how a COVID-19 infection can further worsen an already critical situation, creating a dangerous combination that can be difficult for doctors to manage.
A rare autoimmune blood vessel disease combined with probable Evans syndrome and COVID-19 infection led to
progressive strokes and fatal complications in an elderly patient
Researchers from the Department of Neurology at Yuhuangding Hospital Affiliated to Qingdao University, the Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation, and the National Clinical Medical Research Center for Neurological Diseases Regional Subcenter in Yantai, China, described the tragic case of a 72-year-old woman whose rapidly progressing strokes were ultimately linked to a rare autoimmune condition known as ANCA-associated vasculitis (AAV).
A Mysterious Stroke That Kept Getting Worse
The patient initially developed weakness on the right side of her body and underwent brain imaging that revealed an acute stroke. Standard antiplatelet medications were prescribed, but instead of improving, her condition steadily deteriorated over the following month.
When she was admitted to hospital, doctors found that she had severe weakness on her right side, speech difficulties, anemia, low platelet counts, kidney impairment, and elevated levels of inflammation throughout her body. Brain scans revealed multiple new areas of stroke affecting different regions of the brain. More alarmingly, tiny areas of bleeding were also present within some of the damaged brain tissue.
The unusual pattern of repeated strokes, combined with evidence of disease affecting several organs, suggested that something more than conventional vascular disease was occurring.
A Rare Autoimmune Disease Identified
Further testing revealed extremely high levels of myeloperoxidase antineutrophil cytoplasmic antibodies, known as MPO-ANCA. This finding led doctors to diagnose ANCA-associated vasculitis, a rare autoimmune disorder in which the body's immune system mistakenly attacks blood vessels.
The inflammation caused by AAV can damage blood vessel walls and reduce blood flow to vital organs. While the disease most commonly affects the kidneys, lungs, and small blood vessels, it can also involve the brain.
Researchers noted that stroke is an uncommon but potentially catastrophic manifestation of AAV. In some cases, the disease can affect multiple blood vessels in the brain simultaneously, leading to recurrent strokes that continue despite conventional treatment.
A Second Autoimmune Disorder Complicates the Case
As doctors investigated further, another rare condition emerged. The patient developed worsening anemia and thrombocytopenia, a condition involving dangerously low platelet counts.
Specialized blood
tests indicated probable Evans syndrome, a rare autoimmune disorder in which the immune system destroys red blood cells and platelets. The coexistence of Evans syndrome and ANCA-associated vasculitis is extremely uncommon and may reflect a profound breakdown in the body's immune regulation.
The researchers believe the two conditions likely shared underlying immune mechanisms that caused widespread damage throughout the patient's body.
This
Medical News report highlights how the simultaneous presence of multiple autoimmune disorders can complicate diagnosis and treatment, particularly when the first symptom is a severe neurological event such as stroke.
Progressive Brain Damage Despite Treatment
The medical team immediately started corticosteroid therapy to suppress the abnormal immune response. Intravenous immunoglobulin therapy was later added as blood abnormalities worsened.
Despite treatment, the patient's condition rapidly declined. Follow-up imaging showed worsening brain infarction and complete blockage of the left middle cerebral artery, one of the brain's most important blood vessels. The resulting brain swelling became severe enough to cause dangerous pressure effects within the skull.
During this period of clinical deterioration, the patient tested positive for SARS-CoV-2, the virus that causes COVID-19.
Researchers believe the infection likely aggravated the situation by increasing inflammation and activating clotting pathways already triggered by the autoimmune disease. Although COVID-19 was not considered the original cause of her strokes, it may have significantly worsened the disease course and increased treatment challenges.
Aggressive Treatment Brings Only Partial Improvement
Because of ongoing disease activity, doctors escalated treatment using therapeutic plasma exchange, a procedure designed to remove harmful antibodies from the bloodstream. Cyclophosphamide, a powerful immunosuppressive medication, was also introduced.
The more aggressive treatment strategy improved kidney function and partially corrected the anemia. However, platelet counts remained low and the severe neurological damage persisted.
The patient was eventually discharged with major neurological disabilities. Tragically, she died two months later.
Important Lessons for Clinicians
The researchers emphasized that doctors should consider autoimmune vasculitis in patients who experience unexplained, recurrent, or progressive strokes, especially when accompanied by kidney abnormalities, skin lesions, blood abnormalities, elevated inflammatory markers, or signs of disease affecting multiple organs.
Early diagnosis is particularly important because delays can allow irreversible organ damage to occur before appropriate immunosuppressive treatment is started.
Conclusion
This case demonstrates how ANCA-associated vasculitis can initially present as a devastating and progressive stroke rather than as a classic autoimmune disease. The patient's condition was further complicated by probable Evans syndrome, creating a rare combination of autoimmune disorders that attacked blood vessels, blood cells, kidneys, and the brain simultaneously. The development of COVID-19 during hospitalization likely intensified systemic inflammation and contributed to worsening clinical outcomes. Despite receiving corticosteroids, intravenous immunoglobulin, plasma exchange, and cyclophosphamide, the patient suffered severe neurological injury and eventually died. The findings serve as an important reminder that rare autoimmune diseases should be considered in patients with unexplained or worsening strokes, particularly when accompanied by signs of systemic inflammation or multi-organ involvement. Early ANCA testing and prompt intervention may offer the best opportunity to prevent catastrophic complications and improve survival.
The study findings were published in the peer reviewed journal: Frontiers in Immunology.
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1764226/full
For the latest on stroke and autoimmune conditions, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/coronavirus
Share
Tweet
Share
